Diffuse melanosis arising from metastatic melanoma: Pathogenetic function of elevated melanocyte peptide growth factors

详细信息    查看全文

• 作者：Markus Bö ; hm ; Meinhard Schiller ; Dorothee Nashan ; Rudolf Stadler ; Thomas A. Luger ; Dieter Metze
• 刊名：Journal of the American Academy of Dermatology
• 出版年：2001
• 出版时间：May 2001
• 年：2001
• 卷：44
• 期：5
• 页码：747-754
• 全文大小：333 K

文摘

The origin of diffuse melanosis resulting from metastatic melanoma is unknown. We examined the light microscopic and ultrastructural changes in the skin of an affected 35-year-old woman and determined the peripheral blood levels of melanocyte growth factors. A total of 7 biopsy specimens were examined by light and electron microscopy and immunohistology (S-100, HMB45, MART1, CD68, MAC387). Serum/plasma levels of melanocyte growth factors of the patient were determined by enzyme-linked immunosorbent assays and compared with those of normal volunteers (n = 10) and amelanotic patients with metastatic melanoma (n = 10), matched to the UICC stage of the affected patient. Hyperpigmented but otherwise apparently normal skin of the patient displayed epidermal melanocyte hyperplasia, increased melanogenesis, and dermal pigment stored in histiocytes and other cells along with extracellular deposits. Blood levels of α-melanocyte stimulating hormone, hepatocyte growth factor, and endothelin-1 were significantly elevated in the affected patient. Aberrant production of these factors may not only be responsible for activation of the pigment system in diffuse melanosis of metastatic melanoma, but also for increased proliferation, motility, and pigment incontinence of normal and malignant melanocytes. (J Am Acad Dermatol 2001;44:747-54.)